New and Exciting News from the World of Scleroderma Research- Daniel E. Furst, MD- 2019 Conference

With greater understanding of how scleroderma occurs and better outcome measures, trials of new drugs and new mechanisms of action are beginning to appear - both successes and failures. In alphabetical order, the following will be discussed: Hematological stem cell transplantation, Lenabasum, Nintedanib, Riociquat, Tocilizumab. Finally, research is beginning to learn how to choose the best drug for each person.
Video Production:
Magnus Media Group
www.magnusmediagroup.com
[phone]

[@MrPudd420]

I am fortunate to be in Canada where I can go ahead and self medicate with full-spectrum cannabinoids. I truly believe that is why my scleroderma has been mild.

[@MegaFernando250]

Fantastic news!! I am so grateful for the evolution of the investigation. Thank so much!!

[@emadorabi6492]

Thank you doctor

[@ebi883]

Marvelous infos, thank you for sharing 🥰